NLBloodLogo
ProjectResearch GoalsPerspectives & StoriesNewslettersEventsEducationHome

Get swabbed! Nursing students and representatives from One Match, the Canadian Blood Services' stem cell and marrow network, at the Health Sciences Centre
The One Match program matches potential stem cell donors to patients who require stem cell transplants. If you’re healthy, and between the ages of 17-35, (and especially if you are a guy), you’re eligible to donate – there’s special need for male donors in this age group.



Newfoundland
and Labrador Blood and Immune Disorders Research Advocacy and Education Project

A Project of Dr. Mary-Frances Scully, Associate Professor, Division of Hematology/Oncology, Memorial University of Newfoundland and Dr. Palinder Kamra, Clinical Associate Professor, Department of Pediatrics, Memorial University of Newfoundland

 
Latest Events and Stories


Eastern Health Offers Transitional Program for Cancer Survivors
 
October 7, 2013 – St. John’s, NL: Eastern Health’s Social Work Department at the Dr. H. Bliss Murphy Cancer Centre is offering a free seven-week program for cancer survivors who have been finished treatment from six weeks to two years. The program, titled Cancer Transitions, Moving Beyond Treatment, is designed to provide cancer survivors with support and education about exercise, nutrition, emotional health, well-being and medical management that will help them as they continue on their path to wellness.
 
The program will start October 23, 2013, and run on Wednesdays from 2:00 to 4:30 p.m. for seven weeks at The Works on 17 Westerland Road in St. John's. Sessions will include 30 minutes of exercise, followed by two hours of group discussion, education and support.
 
To register or learn more about the Cancer Transitions, Moving Beyond Treatment program, please call Eastern Health’s Social Work Department at the Dr. H. Bliss Murphy Cancer Centre at (709) 777-7604.

 


Thrombosis, Blood and Immune
Disorders Education and Research
FREE PUBLIC EVENT
September 17, 2013
Johnston GEO Centre,
St. John’s, NL

View the Invitation
 


Cancers of the blood and immune system account for 20 per cent of cancer patients in the province of Newfoundland and Labrador.  Myeloma and lymphoma are the most common blood cancers.  Cancer, diabetes mellitus, stroke, heart disease, blood clots and anemia are highly prevalent in our province.  We have become concerned by the possibility that the number of patients presenting with primary resistant leukemia, lymphoma, and myeloma may be increasing.

The anemia of chronic disease is a very common complication of cancer, inflammatory arthritis, uncontrolled diabetes, kidney disease, inflammatory bowel disease and other inflammatory disorders.  Anemia caused by iron deficiency occurs at all ages; in young children, teenagers, pregnant women and in elderly people with disorders of the digestive system.  Untreated, unrecognized anemia contributes to a decreased quality of life and prolongs hospital stays.

Hemochromatosis is another genetic cause of illness.  These patients accumulate iron in their bodies leading to toxicity.  The incidence of a variety of genetic mutations is known to be elevated in the Newfoundland and Labrador population. 

Five per cent of the population is heterozygous for the Factor V Leiden mutation.  Two per cent of the population is heterozygous for the Prothrombin gene mutation.  These mutations, under certain circumstances, may increase the risk of the individual experiencing venous or arterial clotting problems such as deep venous thrombosis, pulmonary embolism, myocardial infarction and stroke.

Approximately ten thousand individuals in the province are taking oral anticoagulant therapy to prevent further blood clots.  Blood clots are a common complication of cancer therapy, diabetes mellitus as well as being common complications of obesity, inactivity, surgery, injury, cardiac failure, lung failure, inflammatory bowel disease, liver and kidney disease, and other rare illnesses.

In addition to these common disorders, Newfoundland and Labrador has the highest reported rate yet in Canada of rare bleeding disorders.  In particular, there is a very high prevalence of mild hemophilia A and severe Factor XIII deficiency.  In North America, five to 10 per cent of women experience problems with heavy periods or bleeding with pregnancy. Some become severely anemic and can have life threatening bleeding.

In summary, disorders of the blood and immune system affect a very high proportion of the population of Newfoundland and Labrador.  The Newfoundland and Labrador Thrombosis, Blood and Immunology Research and Education Project is designed to promote and develop education and research to address these challenges.